These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 26040902)

  • 1. Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis.
    Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P
    J Psychopharmacol; 2015 Jul; 29(7):753-63. PubMed ID: 26040902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis.
    Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P
    J Affect Disord; 2016 Jan; 190():474-482. PubMed ID: 26551407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
    Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
    Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childrens' learning and behaviour and the association with cheek cell polyunsaturated fatty acid levels.
    Kirby A; Woodward A; Jackson S; Wang Y; Crawford MA
    Res Dev Disabil; 2010; 31(3):731-42. PubMed ID: 20172688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.
    Puri BK; Martins JG
    Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):179-89. PubMed ID: 24560325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.
    Rheims S; Herbillon V; Gaillard S; Mercier C; Villeuve N; Villéga F; Cances C; Castelnau P; Napuri S; de Saint-Martin A; Auvin S; Nguyen The Tich S; Berquin P; de Bellecize J; Milh M; Roy P; Arzimanoglou A; Bodennec J; Bezin L; Kassai B;
    Epilepsia Open; 2024 Apr; 9(2):582-591. PubMed ID: 38173190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: a randomised controlled trial.
    Sinn N; Bryan J; Wilson C
    Prostaglandins Leukot Essent Fatty Acids; 2008; 78(4-5):311-26. PubMed ID: 18514501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies.
    Chang JP; Su KP; Mondelli V; Pariante CM
    Neuropsychopharmacology; 2018 Feb; 43(3):534-545. PubMed ID: 28741625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
    Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C
    Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?].
    Frölich J; Döpfner M
    Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):109-16. PubMed ID: 18622940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials.
    Jiao J; Li Q; Chu J; Zeng W; Yang M; Zhu S
    Am J Clin Nutr; 2014 Dec; 100(6):1422-36. PubMed ID: 25411277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children.
    Schuchardt JP; Huss M; Stauss-Grabo M; Hahn A
    Eur J Pediatr; 2010 Feb; 169(2):149-64. PubMed ID: 19672626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    J Atten Disord; 2015 Nov; 19(11):954-64. PubMed ID: 24214970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Long-Chain Omega-3 Polyunsaturated Fatty Acids on Endothelial Vasodilator Function and Cognition-Are They Interrelated?
    Kuszewski JC; Wong RHX; Howe PRC
    Nutrients; 2017 May; 9(5):. PubMed ID: 28498345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 Polyunsaturated Fatty Acids for Core Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Liu TH; Wu JY; Huang PY; Lai CC; Chang JP; Lin CH; Su KP
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656283
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials.
    Rangel-Huerta OD; Gil A
    Nutr Rev; 2018 Jan; 76(1):1-20. PubMed ID: 29240924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD).
    Banaschewski T; Belsham B; Bloch MH; Ferrin M; Johnson M; Kustow J; Robinson S; Zuddas A
    Nutr Health; 2018 Dec; 24(4):279-284. PubMed ID: 29921155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.
    Cornu C; Mercier C; Ginhoux T; Masson S; Mouchet J; Nony P; Kassai B; Laudy V; Berquin P; Franc N; Le Heuzey MF; Desombre H; Revol O
    Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):377-384. PubMed ID: 28993963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.